Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobRpl Tapered Groovy RP 4.3x11.5mm: medical device reports filed with FDA

4,631 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

4,631
device reports naming the brand
0% of all MAUDE reports · about 678 a year
444
reports, 12 months to August 2026
464 in the 12 months before
0.5%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,631 reports that name the brand "NobRpl Tapered Groovy RP 4.3x11.5mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

444 reports arrived in the 12 months to August 2026, close to the 464 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.5%) and malfunction (0.5%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58%), loss of osseointegration (36.9%) and osseointegration problem (3.1%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0178356Sep 2021: 73Oct 2021: 60Nov 2021: 96Dec 2021: 822022Jan 2022: 33Feb 2022: 44Mar 2022: 40Apr 2022: 43May 2022: 40Jun 2022: 44Jul 2022: 84Aug 2022: 132Sep 2022: 94Oct 2022: 151Nov 2022: 101Dec 2022: 1062023Jan 2023: 31Feb 2023: 45Mar 2023: 118Apr 2023: 95May 2023: 73Jun 2023: 356Jul 2023: 31Aug 2023: 113Sep 2023: 27Oct 2023: 30Nov 2023: 32Dec 2023: 352024Jan 2024: 36Feb 2024: 54Mar 2024: 43Apr 2024: 76May 2024: 39Jun 2024: 32Jul 2024: 48Aug 2024: 48Sep 2024: 64Oct 2024: 48Nov 2024: 25Dec 2024: 622025Jan 2025: 52Feb 2025: 30Mar 2025: 34Apr 2025: 9May 2025: 0Jun 2025: 2Jul 2025: 114Aug 2025: 24Sep 2025: 32Oct 2025: 50Nov 2025: 42Dec 2025: 222026Jan 2026: 78Feb 2026: 48Mar 2026: 38Apr 2026: 42May 2026: 20Jun 2026: 34Jul 2026: 30Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04939862019: 25320192020: 40420202021: 79220212022: 91220222023: 98620232024: 57520242025: 41120252026: 2982026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.5%4,608
Malfunction0.5%23
Other0%0
Not given0%0

Who filed the report

Manufacturer report60.3%2,794
Voluntary report0%0
User facility report0%0
Distributor report39.7%1,837
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,68658%62.8%
Loss of osseointegration1,70736.9%22.4%
Osseointegration problem1453.1%7.7%
Fracturea broken bone300.6%1.6%
Insufficient device problem information70.2%0.2%
Migrationthe device moved from where it was placed60.1%0.1%
Premature separation40.1%0.1%
Malposition of device30.1%0.1%
Separation failure30.1%0.1%
Activation, positioning or separation problem20%0%
Mechanical problema mechanical problem20%0.1%
Device damaged by another device10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant4,03487.1%
Painpain, site not specified47810.3%
Numbnessnumbness932%
Appropriate clinical signs, symptoms and conditions term/code not available641.4%
Abscessa collection of pus360.8%
Implant pain80.2%
Inflammationinflammation80.2%
Osteomyelitis30.1%
Sinus perforation30.1%
Fistula20%
Foreign body in patientpart of a device left in the patient10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobRpl Tapered Groovy RP 4.3x11.5mmProduct code DZEAll MAUDE reports
Reports4,6313,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99.5%99.2%36.2%
Classified as malfunction0.5%0.8%62.3%
Filed by the manufacturer60.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobRpl Tapered Groovy RP 4.3x11.5mm reports

How many FDA reports name NobRpl Tapered Groovy RP 4.3x11.5mm?

4,631 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 444 in the latest 12 months.

What kinds of events are reported?

injury (99.5%) and malfunction (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58%), loss of osseointegration (36.9%), osseointegration problem (3.1%), fracture (0.6%) and insufficient device problem information (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (60.3%) and distributor reports (39.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobRpl Tapered Groovy RP 4.3x11.5mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.